We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ISTA Pharmaceuticals Announces U.S. Patent Allowance for PROLENSA™ in the United States

News   Jan 06, 2012

 
ISTA Pharmaceuticals Announces U.S. Patent Allowance for PROLENSA™ in the United States
 
 
Advertisement
 

RELATED ARTICLES

Redesigning Existing Antibiotics To Outmanoeuver Resistant Bacteria

News

Researchers at UC San Francisco are tackling antibiotic resistance using a different approach: redesigning existing antibiotic molecules to evade a bacterium’s resistance mechanisms.

READ MORE

Study Investigates Racial Disparities in Clinical Trial Recruitment

News

Scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. Little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population.

READ MORE

How Giant Spider Venom Might Help Sufferers of Irritable Bowel Syndrome

News

Molecules from the venom of one of the world’s largest spiders could help a team of Institute for Molecular Bioscience-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE